Cancer gene profiling for response prediction

Methods in Molecular Biology

Volumn 1381, Issue , 2016, Pages 163-179

  Ghadimi, B Michael ^a   Jo, Peter ^a  

^a NONE

Author keywords

Gene expression profiling; Microarrays; Personalized medicine; Preoperative chemoradiotherapy; Rectal cancer; Response prediction

Indexed keywords

GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; PERSONALIZED MEDICINE; RNA HYBRIDIZATION; RNA ISOLATION; TREATMENT RESPONSE; TUMOR GENE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; NEOPLASMS; PROCEDURES; PROGNOSIS; RECTAL NEOPLASMS;

COMPLEMENTARY DNA; RNA;

DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECISION MEDICINE; PROGNOSIS; RECTAL NEOPLASMS; RNA;

EID: 84950342049     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3204-7_9     Document Type: Chapter

References (22)

1. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown Po (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227-35
2. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers Tg, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, Weinstein JN (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24:236-44
3. Mariadason JM, Arango D, Shi Q, Wilson AJ, Corner GA, Nicholas C, Aranes MJ, Lesser M, Schwartz El, Augenlicht LH (2003) Gene expression profiling-based prediction ofresponse of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 63:8791-812
4. Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, Cantor AB, Scuto A, Li Zhang S, Jove R, Yeatman T (2005) Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 65:7169-76
5. Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR (2006) Genomic signatures to guide the use of chemotherapeutics. Nat Med 12:1294-300
6. Lonning PE, Knappskog S, Staalesen V, Chrisanthar R, Lillehaug JR (2007) Breast cancer prognostication and prediction in the post- genomic era. Ann Oncol 18:1293-306
7. Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA (2006) Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24:259-67
8. Del Rio M, Molina F, Bascoul-Mollevi C, Copois V, Bibeau F, Chalbos P, Bareil C, Kramar A, Salvetat N, Fraslon C, Conseiller E, Granci V, Leblanc B, Pau B, Martineau P, Ychou M (2007) Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. J Clin Oncol 25:773-80
9. Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T, Marshall JF, Kocher HM, Crnogorac-Jurcevic T, Scarpa A, Lemoine NR, Chelala C (2014) A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med 6(12):105
10. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-6
11. van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
12. Buyse M, Loi S, van’t Veer L, Viale G, Delorenzi M, Glas AM, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ (2006) TRANSBIG Consortium. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98:1183-92
13. Drukker CA, Bueno-de-Mesquita JM, Retel VP, van Harten WH, van Tinteren H, Wesseling J, Roumen RM, Knauer M, van’t Veer LJ, Sonke GS, Rutgers EJ, van de Vijver MJ, Linn SC (2013) A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study. Int J Cancer 133:929-36
14. Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH Jr, Nevins JR (2006) A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355:570-80
15. Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Ponten F, Konig A, Fernandes O, Karlsson M, Helenius G, Karlsson C, Rahnenfuhrer J, Hengstler JG, Micke P (2013) Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res 19(1):194-204
16. Bogaerts J, Cardoso F, Buyse M, Braga S, Loi S, Harrison JA, Bines J, Mook S, Decker N Ravdin P, Therasse P, Rutgers E, van’t Veer LJ, Piccart M, TRANSBIG Consortium (2006) Gene signature evaluation as a prognostic tool:challenges in the design of the MINDACT trial. Nat Clin Pract Oncol 3:540-51
17. Anguiano A, Potti A (2007) Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer. Expert Rev Mol Diagn 7:837-44
18. Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T, Ried T (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23:1826-38
19. Dangl A, Demiroglu SY, Gaedcke J, Helbing K, Jo P, Rakebrandt F, Rienhoff O, Sax U (2010) The IT-infrastructure of a biobank for an academic medical center. Stud Health Technol Inform 160:1334-8
20. Hall JA, Brown R (2013) Developing translational research infrastructure and capabilities associated with cancer clinical trials. Expert Rev Mol Med 15, e11
21. de Reyniès A, Geromin D, Cayuela JM, Petel F, Dessen P, Sigaux F, Rickman DS (2006) Comparison of the latest commercial short and long oligonucleotide microarray technologies. BMC Genomics 7:51
22. Patterson TA, Lobenhofer EK, Fulmer- Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES, Hager J, Tikhonova IR, Walker SJ, Zhang L, Hurban P, de Longueville F, Fuscoe JC, Tong W, Shi L, Wolfinger RD (2006) Performance comparison of one-color and two-color platforms within the microarray quality control (MAQC) project. Nat Biotechnol 24:1140-50